Business

Thyme Care Raises $125 Million

Updated 2026-09-02 15:25 UTC 1 source Positive

Cancer care startup Thyme Care has secured a $125 million funding round, doubling its valuation to over $2 billion. The company aims to address gaps in critical disease treatment.

Coverage timeline — 1 article

CNBC

Thyme Care raises $125 million, pushing cancer care startup's valuation above $2 billion

Thyme Care has raised $125 million from investors in a deal doubling the cancer startup's valuation as it tackles critical disease treatment gaps.

2026-09-02 15:15 UTC